T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$3.76B |
| 2 |
Cigna
CI
|
+$1.44B |
| 3 |
Bristol-Myers Squibb
BMY
|
+$1.26B |
| 4 |
Occidental Petroleum
OXY
|
+$763M |
| 5 |
Danaher
DHR
|
+$762M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$2.46B |
| 2 |
Wynn Resorts
WYNN
|
+$1.11B |
| 3 |
Netflix
NFLX
|
+$1.03B |
| 4 |
PCP
PRECISION CASTPARTS CORP
PCP
|
+$975M |
| 5 |
TWTR
Twitter, Inc.
TWTR
|
+$909M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 22.87% |
| 2 | Financials | 13.64% |
| 3 | Consumer Discretionary | 13.54% |
| 4 | Industrials | 10.67% |
| 5 | Technology | 10.39% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Viavi Solutions
VIAV
$10.6B
| $265M | 0.05% |
40,233,022
-5,495,153
| -12% | -$40.1M |
|
377
CoStar Group
CSGP
$13.4B
| $263M | 0.05% |
13,072,230
+888,720
| +7% | +$18.1M |
|
|
WFM
378
DELISTED
Whole Foods Market Inc
WFM
| $262M | 0.05% |
6,650,788
+87,787
| +1% | +$3.93M |
|
379
GSK
GSK
$101B
| $259M | 0.05% |
4,980,698
-2,047,108
| -29% | -$115M |
|
380
Texas Capital Bancshares
TCBI
$4.39B
| $259M | 0.05% |
4,154,908
-104,130
| -2% | -$5.7M |
|
381
Kilroy Realty
KRC
$4.3B
| $255M | 0.05% |
3,794,288
+11,992
| +0.3% | +$853K |
|
382
Delta Air Lines
DAL
$60.1B
| $254M | 0.05% |
6,192,298
-179,509
| -3% | -$7.85M |
|
383
Campbell Soup
CPB
$6.94B
| $252M | 0.05% |
5,288,718
+34,300
| +0.7% | +$1.6M |
|
|
SBNY
384
DELISTED
Signature Bank
SBNY
| $251M | 0.05% |
1,716,034
-1,652,839
| -49% | -$230M |
|
385
Louisiana-Pacific
LPX
$5.18B
| $250M | 0.05% |
14,697,454
+1,049,810
| +8% | +$17.8M |
|
386
EOG Resources
EOG
$74.2B
| $250M | 0.05% |
2,854,323
-1,329,569
| -32% | -$123M |
|
387
Cognizant
CTSH
$26.7B
| $249M | 0.05% |
4,083,906
+506,260
| +14% | +$31.8M |
|
|
PX
388
DELISTED
Praxair Inc
PX
| $248M | 0.05% |
2,073,930
-141,707
| -6% | -$17.3M |
|
|
SNDK
389
DELISTED
SANDISK CORP
SNDK
| $248M | 0.05% |
4,257,510
-5,905,952
| -58% | -$395M |
|
390
Western Alliance Bancorporation
WAL
$8.92B
| $246M | 0.05% |
7,298,757
-69,510
| -0.9% | -$2.22M |
|
391
Southern Copper
SCCO
$158B
| $245M | 0.05% |
9,107,802
+580,163
| +7% | +$16.4M |
|
392
Puma Biotechnology
PBYI
$449M
| $245M | 0.05% |
2,094,447
-903,643
| -30% | -$164M |
|
|
PRA
393
DELISTED
ProAssurance
PRA
| $240M | 0.05% |
5,192,358
+1,104,350
| +27% | +$50.2M |
|
|
CLR
394
DELISTED
CONTINENTAL RESOURCES INC.
CLR
| $240M | 0.05% |
5,656,934
-2,951,874
| -34% | -$140M |
|
395
Matador Resources
MTDR
$6.39B
| $240M | 0.05% |
9,586,217
+2,771,254
| +41% | +$74.3M |
|
|
FNFG
396
DELISTED
FIRST NIAGARA FINANCIAL GROUP INC
FNFG
| $239M | 0.05% |
25,369,557
-652,473
| -3% | -$5.96M |
|
|
PFPT
397
DELISTED
Proofpoint, Inc.
PFPT
| $239M | 0.05% |
3,756,900
-130,330
| -3% | -$7.66M |
|
398
Automatic Data Processing
ADP
$110B
| $239M | 0.05% |
2,980,390
-114,232
| -4% | -$9.74M |
|
399
Keurig Dr Pepper
KDP
$42.4B
| $237M | 0.05% |
3,257,039
-173,350
| -5% | -$13.2M |
|
400
CNA Financial
CNA
$13.8B
| $237M | 0.05% |
6,210,607
+9,341
| +0.2% | +$371K |
|
Similar funds
T. Rowe Price Associates's Q2 2015 Portfolio in Review
As of Q2 2015, T. Rowe Price Associates held 2,615 positions worth $486B, up 0.44% from $484B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
T. Rowe Price Associates's Q2 2015 filing shows 76 new, 1,051 increased, 777 reduced and 79 closed positions. Its largest new stake was Allergan plc: 548,825 shares worth $570M. The largest sale was PHARMACYCLICS INC, an estimated $2.46B.
By sector, the portfolio is most concentrated in Healthcare at 23% of assets, up from 21% a quarter earlier, followed by Financials and Consumer Discretionary.
- T. Rowe Price Associates's largest Q2 2015 buy was Allergan plc: 548,825 shares worth $570M.
- T. Rowe Price Associates added most to Microsoft in Q2 2015, an estimated $3.76B increase.
- T. Rowe Price Associates's biggest Q2 2015 reduction was Wynn Resorts, cutting an estimated $1.11B.
- T. Rowe Price Associates fully exited PHARMACYCLICS INC in Q2 2015, selling an estimated $2.46B.
- T. Rowe Price Associates's ten largest holdings make up 14% of its $486B portfolio in Q2 2015.
- T. Rowe Price Associates opened 76 new positions and closed 79 in Q2 2015.
- T. Rowe Price Associates's portfolio value rose 0.44% quarter-over-quarter to $486B.
Based on T. Rowe Price Associates's 13F filing for Q2 2015, filed 14 Aug 2015.